Patents by Inventor Isidro Angelo Eleazar Zarraga

Isidro Angelo Eleazar Zarraga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240123066
    Abstract: The present disclosure provides liquid formulations comprising polypeptides and surfactants. In particular, it discloses a liquid formulation comprising a polypeptide and a surfactant, wherein at least about 70% (wt %) of the surfactant are isosorbide polyoxyethylene (POE) fatty acid esters. The invention also provides methods for making such liquid formulations, articles of manufacture comprising such liquid formulations and methods of treating a patient with such liquid formulations.
    Type: Application
    Filed: December 6, 2023
    Publication date: April 18, 2024
    Applicant: Genentech, Inc.
    Inventors: Anthony TOMLINSON, Barthelemy Luc DEMEULE, Isidro Angelo Eleazar ZARRAGA
  • Patent number: 11865177
    Abstract: The present disclosure provides liquid formulations comprising polypeptides and surfactants. In particular, it discloses a liquid formulation comprising a polypeptide and a surfactant, wherein at least about 70% (wt %) of the surfactant are isosorbide polyoxyethylene (POE) fatty acid esters. The invention also provides methods for making such liquid formulations, articles of manufacture comprising such liquid formulations and methods of treating a patient with such liquid formulations.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: January 9, 2024
    Assignee: GENENTECH, INC.
    Inventors: Anthony Tomlinson, Barthelemy Luc Demeule, Isidro Angelo Eleazar Zarraga
  • Publication number: 20220298263
    Abstract: The present invention relates to methods and formulations useful for reducing the reconstitution time of lyophilized polypeptides.
    Type: Application
    Filed: June 3, 2022
    Publication date: September 22, 2022
    Applicant: Genentech, Inc.
    Inventors: Fredric John LIM, Jacob Edward LUOMA, Isidro Angelo Eleazar ZARRAGA, Christopher Michael HEYNES
  • Patent number: 11377505
    Abstract: The present invention relates to methods and formulations useful for reducing the reconstitution time of lyophilized polypeptides.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: July 5, 2022
    Assignee: Genentech, Inc.
    Inventors: Fredric John Lim, Jacob Edward Luoma, Isidro Angelo Eleazar Zarraga, Christopher Michael Heynes
  • Publication number: 20210015920
    Abstract: The present disclosure provides liquid formulations comprising polypeptides and surfactants. In particular, it discloses a liquid formulation comprising a polypeptide and a surfactant, wherein at least about 70% (wt %) of the surfactant are isosorbide polyoxyethylene (POE) fatty acid esters. The invention also provides methods for making such liquid formulations, articles of manufacture comprising such liquid formulations and methods of treating a patient with such liquid formulations.
    Type: Application
    Filed: June 26, 2020
    Publication date: January 21, 2021
    Applicant: Genentech, Inc.
    Inventors: Anthony TOMLINSON, Barthelemy Luc DEMEULE, Isidro Angelo Eleazar ZARRAGA
  • Publication number: 20190389974
    Abstract: The present invention relates to methods and formulations useful for reducing the reconstitution time of lyophilized polypeptides.
    Type: Application
    Filed: May 23, 2019
    Publication date: December 26, 2019
    Applicant: Genentech, Inc.
    Inventors: Fredric John LIM, Jacob Edward LUOMA, Isidro Angelo Eleazar ZARRAGA, Christopher Michael HEYNES
  • Publication number: 20170319712
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 9, 2017
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: RICHARD L. MILLER, MARK A. TOMAI, ROSS M. KEDL, ISIDRO ANGELO ELEAZAR ZARRAGA, RONNIE ORTIZ, JAMES D. STOESZ, PAUL D. WIGHTMAN
  • Patent number: 9801947
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: October 31, 2017
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Richard L. Miller, Mark A. Tomai, Ross M. Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D. Stoesz, Paul D. Wightman
  • Publication number: 20150044279
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Application
    Filed: October 6, 2014
    Publication date: February 12, 2015
    Inventors: Richard L. Miller, Mark A. Tomai, Ross M. Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D. Stoesz, Paul D. Wightman
  • Publication number: 20040265351
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Application
    Filed: April 9, 2004
    Publication date: December 30, 2004
    Inventors: Richard L. Miller, Mark A. Tomai, Ross M. Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D. Stoesz